Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 62.20
+0.85 (1.39%)
At close: Mar 6, 2026
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 8.08 billion as of March 6, 2026. Its market cap has increased by 22.81% in one year.
Market Cap
8.08B
Enterprise Value
7.29B
Revenue
1.21B
Ranking
n/a
PE Ratio
44.44
Stock Price
62.20
Market Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 8.08B, an increase of 32.94%. That is a compound annual growth rate of 5.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.08B | -13.92% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 8.73B |
| Sino Biological,Inc. | 8.42B |
| Daan Gene | 8.31B |
| Jiangxi Fushine Pharmaceutical | 8.22B |
| Youcare Pharmaceutical Group | 7.93B |
| Nanjing Vazyme Biotech | 7.86B |
| Suzhou Fengbei Biotech Stock | 7.83B |
| Anhui Huaheng Biotechnology | 7.76B |